logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andreas Obermair

frazer institute
H指数:62
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quality of life and patient-reported outcomes after non-surgical management of early-stage endometrial cancer and endometrial hyperplasia with atypia: a long-term follow-up of the feMMe Phase II randomized clinical trial

早期子宫内膜癌和子宫内膜不典型增生非手术治疗后的生活质量与患者报告结局：feMMe II期随机临床试验的长期随访

International Journal of Gynecological Cancer
IF4.7
2026-06-110
OAAI
Katharina Steger; Eva Baxter; Ruqaiya Al Ramadhani; Monika Janda; Andreas Obermair
Response to: Correspondence on “Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial” by Baxter et al.

回复：关于“左炔诺孕酮宫内节育器治疗子宫内膜增生和腺癌的长期肿瘤学和生殖结局——feMMe II期随机临床试验结果”一文的通信，Baxter等人。

International Journal of Gynecological Cancer
IF4.7
2026-05-140
PRE
Eva Baxter; Kristy P. Robledo; Monika Janda; Andreas Obermair
Central Pathology Review of Endometrial Hyperplasia and Adenocarcinoma Before and After Treatment With the Levonorgestrel Intrauterine Device-Results From the feMMe Phase 2 Randomized Clinical Trial

利诺孕酮宫内节育器治疗前后的子宫内膜增生和腺癌中心病理学回顾——feMMe二期随机临床试验结果

AMERICAN JOURNAL OF SURGICAL PATHOLOGY
IF4.2
2026-02-010
PRE
Baxter, Eva; Robledo, Kristy P.; Cummings, Margaret; Alizart, Michelle; Smith, Deborah; Obermair, Andreas
Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]

勘误：‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]

International Journal of Gynecological Cancer
IF4.7
2025-06-110
PRE
Andreas Obermair; Val Gebski; Jeffrey Goh; Anna Kuchel; Alison Brand; Blossom Mak; Orla McNally; Eva Baxter; Thomas Jobling; Linda Mileshkin
Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial

门控FDG PET/CT对可疑或确诊的新诊断晚期上皮性卵巢癌、输卵管癌和原发性腹膜癌患者分期的影响：一项非随机、II期临床试验的结果

International Journal of Gynecological Cancer
IF4.7
2025-04-190
PRE
Florencia Virili; Andreas Obermair; Saira Sanjida; James L. Nicklin; Andrea Garrett; Russell Land; Amy Tang; Louise Campbell; Val Gebski; Paul Thomas
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer

用于宫颈癌患者定制监测策略的年度复发风险模型

EUROPEAN JOURNAL OF CANCER
IF7.1
2021-11-0129
OAAI
Cibula, David; Dostalek, Lukas; Jarkovsky, Jiri; Mom, Constantijne H.; Lopez, Aldo; Falconer, Henrik; Fagotti, Anna; Ayhan, Ali; Kim, Sarah H.; Ortiz, David Isla; Klat, Jaroslav; Obermair, Andreas; Landoni, Fabio; Rodriguez, Juliana; Manchanda, Ranjit; Kostun, Jan; dos Reis, Ricardo; Meydanli, Mehmet M.; Odetto, Diego; Laky, Rene; Zapardiel, Ignacio; Weinberger, Vit; Benesova, Klara; Borcinova, Martina; Pari, Darwin; Salehi, Sahar; Bizzarri, Nicolo; Akilli, Huseyin; Abu-Rustum, Nadeem R.; Salcedo-Hernandez, Rosa A.; Javurkova, Veronika; Slama, Jiri; van Lonkhuijzen, Luc R. C. W.

研究方向

暂未获取到该数据
M
Monika Janda
H 指数:54论文数:592被引数:1.2万
V
Val Gebski
H 指数:86论文数:752被引数:3.5万
P
Penelope M. Webb
H 指数:83论文数:895被引数:3.1万
S
Sepp Leodolter
H 指数:46论文数:361被引数:9,929
A
Alexandra Kaider
H 指数:63论文数:511被引数:1.3万
J
James Nicklin
H 指数:38论文数:143被引数:6,593
E
Eva Baxter
H 指数:9论文数:21被引数:589
R
Robert Zeillinger
H 指数:60论文数:415被引数:1.1万
P
P. Sevelda
H 指数:35论文数:371被引数:6,278
A
Amanda B. Spurdle
H 指数:95论文数:816被引数:4.0万